New Members Added to BioTime’s Board of Directors
BioTime, Inc. elects 4 new members to its Board of Directors.
July 7, 2009
BioTime, Inc. elects 4 new members to its Board of Directors.
The U.S. National Institutes of Health releases the final version of its widely anticipated stem cell guidelines.
Researchers in England announce the creation of human sperm from embryonic stem cells.
Geron Corporation and General Electric have announced the signing of a global licensing agreement for the development and commercialization of embryonic stem cell technology in drug screening.
The adult stem cell product Prochymal, developed by Osiris Therapeutics, is now being used in the treatment of type I diabetes.
Doctors in Los Angeles are testing a method for using the heart’s own stem cells to heal damaged heart tissue.
Toll Free:
1-800-980-STEM (7836)
Outside or Inside US Call:
1-954-358-3382
Toll Free Fax (US Only):
1-866-755-3951
From Outside US Fax:
1-775-887-1194
Copyright 2025, Stem Cell Insitute Panama. All rights reserved.